Clinical Gastroenterology And Hepatology杂志是一本国际顶尖期刊，是一本未开放获取期刊。该杂志近三年影响因子分别为：2023年11.6、2022年12.6、2021年13.576。该杂志近三年CiteScore评价分区分别为：2023年16.9区、2022年14.9区、2021年12.2区。该刊专门致力于推进GASTROENTEROLOGY & HEPATOLOGY领域的研究，涵盖了GASTROENTEROLOGY & HEPATOLOGY领域的各个方面，汇集所有专家，促进GASTROENTEROLOGY & HEPATOLOGY领域的更好协作和信息共享。该期刊为GASTROENTEROLOGY & HEPATOLOGY领域的科研人员提供了一个高影响力的论坛，使该领域的科研人员、从业人员和学生能够接触到尖端的经验性调查分析、学术对话以及行业科研成果的最新发展。通过收录高质量的原创论文和评论论文，促进GASTROENTEROLOGY & HEPATOLOGY领域的应用与发展。该期刊还将该领域的创新与应用，以提高研究的质量和实用性。近年来在该刊上发文的国家和地区主要有：Wales（发文量2）、Uruguay（发文量3）、Ukraine（发文量2）、USA（发文量991）、Turkey（发文量10）、Tunisia（发文量3）。

Clinical Gastroenterology And Hepatology是一本由W.B. Saunders Ltd出版社发行的知名GASTROENTEROLOGY & HEPATOLOGY期刊。该杂志社联系方式ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, USA, NY, 10010-1710。审稿过程是确保期刊质量的关键环节。Clinical Gastroenterology And Hepatology杂志的审稿速度平均需要 约6.5月 。这一时间周期既体现了编辑部对稿件质量的严格把关，也反映了审稿专家对学术研究的尊重和支持。在这个过程中，作者们可以充分利用这段时间对自己的研究成果进行完善和优化，以提高论文的质量和影响力。如果您对该期刊感兴趣，并希望了解更多关于投稿流程、投稿要求和技巧的信息，您可以咨询本站的客服老师，我们将帮助您了解期刊的投稿要求、审稿流程以及可能遇到的问题，并根据您的具体情况提供相应的建议和解决方案。

Clinical Gastroenterology And Hepatology杂志近期中国学者发表的论文主要有：

• 1、Prospective Multicenter Study of the Primary Obesity Surgery Endoluminal (POSE 2.0) Procedure for Treatment of ObesityAuthor: Nava, Gontrand Lopez; Arau, Roman Turro; Asokkumar, Ravishankar; Maselli, Daniel B.; Rapaka, Babusai; Matar, Reem; Bautista, Inmaculada; Perez, Jorge Carlos Espinos; Bilbao, Alfredo Mata; Jaruvongvanich, Veeravich; Vargas, Eric J.; Storm, Andrew C.; Neto, Manoel Galvao; Abu Dayyeh, Barham K.
• 2、Performance of Noninvasive Tests of Fibrosis Among Asians, Hispanic, and non-Hispanic Whites in the STELLAR TrialsAuthor: Wong, Vincent Wai-Sun; Tak, Won Young; Goh, George Boon Bee; Cheng, Pin-Nan; Lawitz, Eric J.; Younossi, Zobair M.; Vuppalanchi, Raj; Younes, Ziad; Alkhouri, Naim; Wang, Lulu; Liu, Jialuo; Kersey, Kathryn; Myers, Robert P.; Harrison, Stephen A.; Goodman, Zachary; Trauner, Michael; Romero-Gomez, Manuel; Anstee, Quentin M.; Nguyen, Mindie H.; Okanoue, Takeshi
• 3、Artificial Intelligence-Assisted Colonoscopy for Colorectal Cancer Screening: A Multicenter Randomized Controlled TrialAuthor: Xu, Hong; Tang, Raymond S. Y.; Lam, Thomas Y. T.; Zhao, Guijun; Lau, James Y. W.; Liu, Yunpeng; Wu, Qi; Rong, Long; Xu, Weiran; Li, Xue; Wong, Sunny H.; Cai, Shuntian; Wang, Jing; Liu, Guanyi; Ma, Tantan; Liang, Xiong; Mak, Joyce W. Y.; Xu, Hongzhi; Yuan, Peng; Cao, Tingting; Li, Fudong; Ye, Zhenshi; Shutian, Zhang; Sung, Joseph J. Y.
• 4、Predicting the Onset of Hepatitis B Virus-Related Acute-on-Chronic Liver FailureAuthor: Luo, Jinjin; Liang, Xi; Xin, Jiaojiao; Li, Jiaqi; Li, Peng; Zhou, Qian; Hao, Shaorui; Zhang, Huafen; Lu, Yingyan; Wu, Tianzhou; Yang, Lingling; Li, Jiang; Li, Tan; Ren, Keke; Guo, Beibei; Zhou, Xingping; Chen, Jiaxian; He, Lulu; Yang, Hui; Hu, Wen; You, Shaoli; Xin, Shaojie; Jiang, Jing; Shi, Dongyan; Chen, Xin; Li, Jun
• 5、Risk-Adapted Starting Age for Personalized Colorectal Cancer Screening: Validated Evidence From National Population-Based StudiesAuthor: Dong, Xuesi; Luo, Zilin; Wu, Zheng; Hang, Dong; Xia, Changfa; Wang, Fei; Zheng, Yadi; Yu, Yiwen; Xu, Yongjie; Cao, Wei; Qin, Chao; Zhao, Liang; Li, Jiang; Ren, Jiansong; Shi, Jufang; Du, Mulong; Chen, Wanqing; Shen, Hongbing; Li, Ni; He, Jie
• 6、Comparison of Colonoscopy, Fecal Immunochemical Test, and Risk-Adapted Approach in a Colorectal Cancer Screening Trial (TARGET-C)Author: Chen, Hongda; Shi, Jufang; Lu, Ming; Li, Yanjie; Du, Lingbin; Liao, Xianzhen; Wei, Donghua; Dong, Dong; Gao, Yi; Zhu, Chen; Ying, Rongbiao; Zheng, Weifang; Yan, Shipeng; Xiao, Haifan; Zhang, Juan; Kong, Yunxin; Li, Furong; Zou, Shuangmei; Liu, Chengcheng; Wang, Hong; Zhang, Yuhan; Lu, Bin; Luo, Chenyu; Cai, Jie; Tian, Jianbo; Miao, Xiaoping; Ding, Kefeng; Brenner, Hermann; Dai, Min